← Insider buys
PCRX

Pacira BioSciences, Inc. · Healthcare

CEO and Chair David M Stack sold $399K of Pacira BioSciences, Inc.

Sold$398,885
$38.41Price
10,384Shares
−4%Stake

What PCRX did after the filing

Filed Jun 7Copier in Jun 8
The stock from Thu, Jun 8 open, $37.38
−1.4%
S&P 500, same days
+6.9%

Measured over 30 trading days, to the Jul 24 close.

Traded Tue, Jun 6. Filed Wed, Jun 7, 5:33 PM ET, after the close. Returns use the Jun 8 open and the Jul 24 close. Not investment advice.